Crinetics Pharmaceuticals (CRNX) Interest Coverage Ratio (2017)

Crinetics Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 1.15 for Q1 2026.

• In Q1 2026, Interest Coverage Ratio rose 97.93% year-over-year to 1.15; the TTM figure through Mar 2026 stood at 4.49 (up 98.25% YoY), while the FY2025 annual figure was 1.32, down 31.35% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 1.15, up from 80.42 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 61.09 in Q4 2024, with the low at 158.52 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 1.57 (2022), against an average of 19.74.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio jumped 169.8% in 2024, then sank 25788.49% in 2025.
• Crinetics Pharmaceuticals' Interest Coverage Ratio stood at 158.52 in 2022, then surged by 44.79% to 87.51 in 2023, then surged by 169.8% to 61.09 in 2024, then slumped by 231.66% to 80.42 in 2025, then jumped by 98.56% to 1.15 in 2026.
• Business Quant data shows CRNX's Interest Coverage Ratio at 1.15 in Q1 2026, 80.42 in Q4 2025, and 0.71 in Q3 2025.